世界のモノシアロテトラヘキソシルガングリオシド市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Monosialotetrahexosylganglioside Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3913
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、モノシアロテトラヘキソシルガングリオシドのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口剤、注射）、用途別市場規模（脳卒中外傷、脳血管障害、パーキンソン病）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・モノシアロテトラヘキソシルガングリオシドの市場動向
・企業の競争状況、市場シェア
・モノシアロテトラヘキソシルガングリオシドの種類別市場規模（経口剤、注射）
・モノシアロテトラヘキソシルガングリオシドの用途別市場規模（脳卒中外傷、脳血管障害、パーキンソン病）
・モノシアロテトラヘキソシルガングリオシドの北米市場規模2016-2027（アメリカ、カナダ）
・モノシアロテトラヘキソシルガングリオシドのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・モノシアロテトラヘキソシルガングリオシドのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・モノシアロテトラヘキソシルガングリオシドの中南米市場規模2016-2027（メキシコ、ブラジル）
・モノシアロテトラヘキソシルガングリオシドの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Qilu Pharmaceutical、Heilongjiang Harbin Medical University Pharmaceutical、Beijing Sihuan Pharmaceutical、Beijing Saisheng Pharmaceutical、Jilin Yinglian Biopharmaceutical、Southwest Pharmaceutical、Changchun Xiangtong Pharmaceutical）
・結論

Monosialotetrahexosylganglioside is used to treat patients with central nervous system lesions including brain crest trauma, cerebrovascular accident, and Parkinson’s disease.

Market Analysis and Insights: Global Monosialotetrahexosylganglioside Market
The global Monosialotetrahexosylganglioside market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Monosialotetrahexosylganglioside market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Monosialotetrahexosylganglioside market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Monosialotetrahexosylganglioside market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Monosialotetrahexosylganglioside market.

Global Monosialotetrahexosylganglioside Scope and Market Size
Monosialotetrahexosylganglioside market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Monosialotetrahexosylganglioside market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral Agents
Injection

Segment by Application
Brain Crest Trauma
Cerebrovascular Accident
Parkinson’S Disease

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Qilu Pharmaceutical
Heilongjiang Harbin Medical University Pharmaceutical
Beijing Sihuan Pharmaceutical
Beijing Saisheng Pharmaceutical
Jilin Yinglian Biopharmaceutical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monosialotetrahexosylganglioside Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Agents
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Monosialotetrahexosylganglioside Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Brain Crest Trauma
1.3.3 Cerebrovascular Accident
1.3.4 Parkinson’S Disease
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Monosialotetrahexosylganglioside Market Perspective (2016-2027)
2.2 Monosialotetrahexosylganglioside Growth Trends by Regions
2.2.1 Monosialotetrahexosylganglioside Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Monosialotetrahexosylganglioside Historic Market Share by Regions (2016-2021)
2.2.3 Monosialotetrahexosylganglioside Forecasted Market Size by Regions (2022-2027)
2.3 Monosialotetrahexosylganglioside Industry Dynamic
2.3.1 Monosialotetrahexosylganglioside Market Trends
2.3.2 Monosialotetrahexosylganglioside Market Drivers
2.3.3 Monosialotetrahexosylganglioside Market Challenges
2.3.4 Monosialotetrahexosylganglioside Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Monosialotetrahexosylganglioside Players by Revenue
3.1.1 Global Top Monosialotetrahexosylganglioside Players by Revenue (2016-2021)
3.1.2 Global Monosialotetrahexosylganglioside Revenue Market Share by Players (2016-2021)
3.2 Global Monosialotetrahexosylganglioside Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Monosialotetrahexosylganglioside Revenue
3.4 Global Monosialotetrahexosylganglioside Market Concentration Ratio
3.4.1 Global Monosialotetrahexosylganglioside Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monosialotetrahexosylganglioside Revenue in 2020
3.5 Monosialotetrahexosylganglioside Key Players Head office and Area Served
3.6 Key Players Monosialotetrahexosylganglioside Product Solution and Service
3.7 Date of Enter into Monosialotetrahexosylganglioside Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Monosialotetrahexosylganglioside Breakdown Data by Type
4.1 Global Monosialotetrahexosylganglioside Historic Market Size by Type (2016-2021)
4.2 Global Monosialotetrahexosylganglioside Forecasted Market Size by Type (2022-2027)

5 Monosialotetrahexosylganglioside Breakdown Data by Application
5.1 Global Monosialotetrahexosylganglioside Historic Market Size by Application (2016-2021)
5.2 Global Monosialotetrahexosylganglioside Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Monosialotetrahexosylganglioside Market Size (2016-2027)
6.2 North America Monosialotetrahexosylganglioside Market Size by Type
6.2.1 North America Monosialotetrahexosylganglioside Market Size by Type (2016-2021)
6.2.2 North America Monosialotetrahexosylganglioside Market Size by Type (2022-2027)
6.2.3 North America Monosialotetrahexosylganglioside Market Size by Type (2016-2027)
6.3 North America Monosialotetrahexosylganglioside Market Size by Application
6.3.1 North America Monosialotetrahexosylganglioside Market Size by Application (2016-2021)
6.3.2 North America Monosialotetrahexosylganglioside Market Size by Application (2022-2027)
6.3.3 North America Monosialotetrahexosylganglioside Market Size by Application (2016-2027)
6.4 North America Monosialotetrahexosylganglioside Market Size by Country
6.4.1 North America Monosialotetrahexosylganglioside Market Size by Country (2016-2021)
6.4.2 North America Monosialotetrahexosylganglioside Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Monosialotetrahexosylganglioside Market Size (2016-2027)
7.2 Europe Monosialotetrahexosylganglioside Market Size by Type
7.2.1 Europe Monosialotetrahexosylganglioside Market Size by Type (2016-2021)
7.2.2 Europe Monosialotetrahexosylganglioside Market Size by Type (2022-2027)
7.2.3 Europe Monosialotetrahexosylganglioside Market Size by Type (2016-2027)
7.3 Europe Monosialotetrahexosylganglioside Market Size by Application
7.3.1 Europe Monosialotetrahexosylganglioside Market Size by Application (2016-2021)
7.3.2 Europe Monosialotetrahexosylganglioside Market Size by Application (2022-2027)
7.3.3 Europe Monosialotetrahexosylganglioside Market Size by Application (2016-2027)
7.4 Europe Monosialotetrahexosylganglioside Market Size by Country
7.4.1 Europe Monosialotetrahexosylganglioside Market Size by Country (2016-2021)
7.4.2 Europe Monosialotetrahexosylganglioside Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Monosialotetrahexosylganglioside Market Size (2016-2027)
8.2 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Type
8.2.1 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Type (2016-2027)
8.3 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Application
8.3.1 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Application (2016-2027)
8.4 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Region
8.4.1 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Monosialotetrahexosylganglioside Market Size (2016-2027)
9.2 Latin America Monosialotetrahexosylganglioside Market Size by Type
9.2.1 Latin America Monosialotetrahexosylganglioside Market Size by Type (2016-2021)
9.2.2 Latin America Monosialotetrahexosylganglioside Market Size by Type (2022-2027)
9.2.3 Latin America Monosialotetrahexosylganglioside Market Size by Type (2016-2027)
9.3 Latin America Monosialotetrahexosylganglioside Market Size by Application
9.3.1 Latin America Monosialotetrahexosylganglioside Market Size by Application (2016-2021)
9.3.2 Latin America Monosialotetrahexosylganglioside Market Size by Application (2022-2027)
9.3.3 Latin America Monosialotetrahexosylganglioside Market Size by Application (2016-2027)
9.4 Latin America Monosialotetrahexosylganglioside Market Size by Country
9.4.1 Latin America Monosialotetrahexosylganglioside Market Size by Country (2016-2021)
9.4.2 Latin America Monosialotetrahexosylganglioside Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Monosialotetrahexosylganglioside Market Size (2016-2027)
10.2 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Type
10.2.1 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Type (2016-2027)
10.3 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Application
10.3.1 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Application (2016-2027)
10.4 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Country
10.4.1 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Qilu Pharmaceutical
11.1.1 Qilu Pharmaceutical Company Details
11.1.2 Qilu Pharmaceutical Business Overview
11.1.3 Qilu Pharmaceutical Monosialotetrahexosylganglioside Introduction
11.1.4 Qilu Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2016-2021)
11.1.5 Qilu Pharmaceutical Recent Development
11.2 Heilongjiang Harbin Medical University Pharmaceutical
11.2.1 Heilongjiang Harbin Medical University Pharmaceutical Company Details
11.2.2 Heilongjiang Harbin Medical University Pharmaceutical Business Overview
11.2.3 Heilongjiang Harbin Medical University Pharmaceutical Monosialotetrahexosylganglioside Introduction
11.2.4 Heilongjiang Harbin Medical University Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2016-2021)
11.2.5 Heilongjiang Harbin Medical University Pharmaceutical Recent Development
11.3 Beijing Sihuan Pharmaceutical
11.3.1 Beijing Sihuan Pharmaceutical Company Details
11.3.2 Beijing Sihuan Pharmaceutical Business Overview
11.3.3 Beijing Sihuan Pharmaceutical Monosialotetrahexosylganglioside Introduction
11.3.4 Beijing Sihuan Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2016-2021)
11.3.5 Beijing Sihuan Pharmaceutical Recent Development
11.4 Beijing Saisheng Pharmaceutical
11.4.1 Beijing Saisheng Pharmaceutical Company Details
11.4.2 Beijing Saisheng Pharmaceutical Business Overview
11.4.3 Beijing Saisheng Pharmaceutical Monosialotetrahexosylganglioside Introduction
11.4.4 Beijing Saisheng Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2016-2021)
11.4.5 Beijing Saisheng Pharmaceutical Recent Development
11.5 Jilin Yinglian Biopharmaceutical
11.5.1 Jilin Yinglian Biopharmaceutical Company Details
11.5.2 Jilin Yinglian Biopharmaceutical Business Overview
11.5.3 Jilin Yinglian Biopharmaceutical Monosialotetrahexosylganglioside Introduction
11.5.4 Jilin Yinglian Biopharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2016-2021)
11.5.5 Jilin Yinglian Biopharmaceutical Recent Development
11.6 Southwest Pharmaceutical
11.6.1 Southwest Pharmaceutical Company Details
11.6.2 Southwest Pharmaceutical Business Overview
11.6.3 Southwest Pharmaceutical Monosialotetrahexosylganglioside Introduction
11.6.4 Southwest Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2016-2021)
11.6.5 Southwest Pharmaceutical Recent Development
11.7 Changchun Xiangtong Pharmaceutical
11.7.1 Changchun Xiangtong Pharmaceutical Company Details
11.7.2 Changchun Xiangtong Pharmaceutical Business Overview
11.7.3 Changchun Xiangtong Pharmaceutical Monosialotetrahexosylganglioside Introduction
11.7.4 Changchun Xiangtong Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2016-2021)
11.7.5 Changchun Xiangtong Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Monosialotetrahexosylganglioside Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Agents
Table 3. Key Players of Injection
Table 4. Global Monosialotetrahexosylganglioside Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Monosialotetrahexosylganglioside Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Monosialotetrahexosylganglioside Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Monosialotetrahexosylganglioside Market Share by Regions (2016-2021)
Table 8. Global Monosialotetrahexosylganglioside Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Monosialotetrahexosylganglioside Market Share by Regions (2022-2027)
Table 10. Monosialotetrahexosylganglioside Market Trends
Table 11. Monosialotetrahexosylganglioside Market Drivers
Table 12. Monosialotetrahexosylganglioside Market Challenges
Table 13. Monosialotetrahexosylganglioside Market Restraints
Table 14. Global Monosialotetrahexosylganglioside Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Monosialotetrahexosylganglioside Market Share by Players (2016-2021)
Table 16. Global Top Monosialotetrahexosylganglioside Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monosialotetrahexosylganglioside as of 2020)
Table 17. Ranking of Global Top Monosialotetrahexosylganglioside Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Monosialotetrahexosylganglioside Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Monosialotetrahexosylganglioside Product Solution and Service
Table 21. Date of Enter into Monosialotetrahexosylganglioside Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Monosialotetrahexosylganglioside Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Monosialotetrahexosylganglioside Revenue Market Share by Type (2016-2021)
Table 25. Global Monosialotetrahexosylganglioside Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Monosialotetrahexosylganglioside Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Monosialotetrahexosylganglioside Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Monosialotetrahexosylganglioside Revenue Market Share by Application (2016-2021)
Table 29. Global Monosialotetrahexosylganglioside Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Monosialotetrahexosylganglioside Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Monosialotetrahexosylganglioside Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Monosialotetrahexosylganglioside Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Monosialotetrahexosylganglioside Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Monosialotetrahexosylganglioside Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Monosialotetrahexosylganglioside Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Monosialotetrahexosylganglioside Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Monosialotetrahexosylganglioside Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Monosialotetrahexosylganglioside Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Monosialotetrahexosylganglioside Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Monosialotetrahexosylganglioside Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Monosialotetrahexosylganglioside Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Monosialotetrahexosylganglioside Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Monosialotetrahexosylganglioside Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Monosialotetrahexosylganglioside Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Monosialotetrahexosylganglioside Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Monosialotetrahexosylganglioside Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Monosialotetrahexosylganglioside Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Monosialotetrahexosylganglioside Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Monosialotetrahexosylganglioside Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Monosialotetrahexosylganglioside Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Monosialotetrahexosylganglioside Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Monosialotetrahexosylganglioside Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Monosialotetrahexosylganglioside Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Monosialotetrahexosylganglioside Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Monosialotetrahexosylganglioside Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Monosialotetrahexosylganglioside Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Monosialotetrahexosylganglioside Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Monosialotetrahexosylganglioside Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Monosialotetrahexosylganglioside Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Monosialotetrahexosylganglioside Market Size by Country (2022-2027) & (US$ Million)
Table 61. Qilu Pharmaceutical Company Details
Table 62. Qilu Pharmaceutical Business Overview
Table 63. Qilu Pharmaceutical Monosialotetrahexosylganglioside Product
Table 64. Qilu Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2016-2021) & (US$ Million)
Table 65. Qilu Pharmaceutical Recent Development
Table 66. Heilongjiang Harbin Medical University Pharmaceutical Company Details
Table 67. Heilongjiang Harbin Medical University Pharmaceutical Business Overview
Table 68. Heilongjiang Harbin Medical University Pharmaceutical Monosialotetrahexosylganglioside Product
Table 69. Heilongjiang Harbin Medical University Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2016-2021) & (US$ Million)
Table 70. Heilongjiang Harbin Medical University Pharmaceutical Recent Development
Table 71. Beijing Sihuan Pharmaceutical Company Details
Table 72. Beijing Sihuan Pharmaceutical Business Overview
Table 73. Beijing Sihuan Pharmaceutical Monosialotetrahexosylganglioside Product
Table 74. Beijing Sihuan Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2016-2021) & (US$ Million)
Table 75. Beijing Sihuan Pharmaceutical Recent Development
Table 76. Beijing Saisheng Pharmaceutical Company Details
Table 77. Beijing Saisheng Pharmaceutical Business Overview
Table 78. Beijing Saisheng Pharmaceutical Monosialotetrahexosylganglioside Product
Table 79. Beijing Saisheng Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2016-2021) & (US$ Million)
Table 80. Beijing Saisheng Pharmaceutical Recent Development
Table 81. Jilin Yinglian Biopharmaceutical Company Details
Table 82. Jilin Yinglian Biopharmaceutical Business Overview
Table 83. Jilin Yinglian Biopharmaceutical Monosialotetrahexosylganglioside Product
Table 84. Jilin Yinglian Biopharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2016-2021) & (US$ Million)
Table 85. Jilin Yinglian Biopharmaceutical Recent Development
Table 86. Southwest Pharmaceutical Company Details
Table 87. Southwest Pharmaceutical Business Overview
Table 88. Southwest Pharmaceutical Monosialotetrahexosylganglioside Product
Table 89. Southwest Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2016-2021) & (US$ Million)
Table 90. Southwest Pharmaceutical Recent Development
Table 91. Changchun Xiangtong Pharmaceutical Company Details
Table 92. Changchun Xiangtong Pharmaceutical Business Overview
Table 93. Changchun Xiangtong Pharmaceutical Monosialotetrahexosylganglioside Product
Table 94. Changchun Xiangtong Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2016-2021) & (US$ Million)
Table 95. Changchun Xiangtong Pharmaceutical Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monosialotetrahexosylganglioside Market Share by Type: 2020 VS 2027
Figure 2. Oral Agents Features
Figure 3. Injection Features
Figure 4. Global Monosialotetrahexosylganglioside Market Share by Application: 2020 VS 2027
Figure 5. Brain Crest Trauma Case Studies
Figure 6. Cerebrovascular Accident Case Studies
Figure 7. Parkinson'S Disease Case Studies
Figure 8. Monosialotetrahexosylganglioside Report Years Considered
Figure 9. Global Monosialotetrahexosylganglioside Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Monosialotetrahexosylganglioside Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Monosialotetrahexosylganglioside Market Share by Regions: 2020 VS 2027
Figure 12. Global Monosialotetrahexosylganglioside Market Share by Regions (2022-2027)
Figure 13. Global Monosialotetrahexosylganglioside Market Share by Players in 2020
Figure 14. Global Top Monosialotetrahexosylganglioside Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monosialotetrahexosylganglioside as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Monosialotetrahexosylganglioside Revenue in 2020
Figure 16. Global Monosialotetrahexosylganglioside Revenue Market Share by Type (2016-2021)
Figure 17. Global Monosialotetrahexosylganglioside Revenue Market Share by Type (2022-2027)
Figure 18. North America Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Monosialotetrahexosylganglioside Market Share by Type (2016-2027)
Figure 20. North America Monosialotetrahexosylganglioside Market Share by Application (2016-2027)
Figure 21. North America Monosialotetrahexosylganglioside Market Share by Country (2016-2027)
Figure 22. United States Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Monosialotetrahexosylganglioside Market Share by Type (2016-2027)
Figure 26. Europe Monosialotetrahexosylganglioside Market Share by Application (2016-2027)
Figure 27. Europe Monosialotetrahexosylganglioside Market Share by Country (2016-2027)
Figure 28. Germany Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Monosialotetrahexosylganglioside Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Monosialotetrahexosylganglioside Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Monosialotetrahexosylganglioside Market Share by Region (2016-2027)
Figure 38. China Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Monosialotetrahexosylganglioside Market Share by Type (2016-2027)
Figure 46. Latin America Monosialotetrahexosylganglioside Market Share by Application (2016-2027)
Figure 47. Latin America Monosialotetrahexosylganglioside Market Share by Country (2016-2027)
Figure 48. Mexico Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Monosialotetrahexosylganglioside Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Monosialotetrahexosylganglioside Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Monosialotetrahexosylganglioside Market Share by Country (2016-2027)
Figure 54. Turkey Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Monosialotetrahexosylganglioside Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Qilu Pharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2016-2021)
Figure 58. Heilongjiang Harbin Medical University Pharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2016-2021)
Figure 59. Beijing Sihuan Pharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2016-2021)
Figure 60. Beijing Saisheng Pharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2016-2021)
Figure 61. Jilin Yinglian Biopharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2016-2021)
Figure 62. Southwest Pharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2016-2021)
Figure 63. Changchun Xiangtong Pharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界の医薬品界面活性剤市場規模・現状・予測（2021年-2027年）

Global Pharmaceutical Surfactants Market Size, Status and Forecast 2021-2027
QYR2104Z4569 2021年4月 96Pages
QYResearch社発行の本調査資料では、医薬品界面活性剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（陰イオン界面活性剤、陽イオン界面活性剤、両性界面活性剤、非イオン界面活性剤、その他）、用途別市場規模（乳化剤、抗菌剤、プロバイオティクス...

世界の医薬品界面活性剤市場規模・現状・予測（2021年-2027年）

世界の医薬品資産管理市場規模・現状・予測（2021年-2027年）

Global Pharmaceutical Asset Managements Market Size, Status and Forecast 2021-2027
QYR2104Z4556 2021年4月 99Pages
QYResearch社発行の本調査資料では、医薬品資産管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ハードウェア（製薬資産）、ソフトウェア（製薬資産））、用途別市場規模（医薬品偽造防止、サプライチェーン管理、その他）、主要地域別市場規模（...

世界の医薬品資産管理市場規模・現状・予測（2021年-2027年）

Global Pharmaceutical Asset Management Market Size, Status and Forecast 2021-2027
QYR2104Z4555 2021年4月 93Pages
QYResearch社発行の本調査資料では、医薬品資産管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ハードウェア（製薬資産）、ソフトウェア（製薬資産））、用途別市場規模（医薬品偽造防止、サプライチェーン管理）、主要地域別市場規模（北米、ア...

世界の医薬品用酸化ストレスアッセイ市場規模・現状・予測（2021年-2027年）

Global Oxidative Stress Assay for Pharmaceutical Market Size, Status and Forecast 2021-2027
QYR2104Z4391 2021年4月 96Pages
QYResearch社発行の本調査資料では、医薬品用酸化ストレスアッセイのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（消耗品、機器、サービス）、用途別市場規模（研究機関、病院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の医薬品連続生産市場規模・現状・予測（2021年-2027年）

Global Pharmaceutical Continuous Manufacturing Market Size, Status and Forecast 2021-2027
QYR2104Z4560 2021年4月 96Pages
QYResearch社発行の本調査資料では、医薬品連続生産のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医薬品有効成分、生物製剤、乾燥粉末）、用途別市場規模（製薬会社、医薬品製造受託機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界のビッグデータ医薬品広告市場規模・現状・予測（2021年-2027年）

Global Big Data Pharmaceutical Advertising Market Size, Status and Forecast 2021-2027
QYR2104Z0761 2021年4月 92Pages
QYResearch社発行の本調査資料では、ビッグデータ医薬品広告のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（製品ウェブサイト・Eコマース、ソーシャルメディア、検索エンジン、モバイル広告）、用途別市場規模（製品・サービスターゲティング、顧客...

世界の化学薬品市場規模・現状・予測（2021年-2027年）

Global Chemical Pharmaceutical Market Size, Status and Forecast 2021-2027
QYR2104Z1263 2021年4月 98Pages
QYResearch社発行の本調査資料では、化学薬品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口用医薬品、注射用医薬品、外用医薬品、その他）、用途別市場規模（製薬産業、研究機関、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、...

世界の医薬化学品市場規模・現状・予測（2021年-2027年）

Global Pharmaceutical Chemicals Market Size, Status and Forecast 2021-2027
QYR2104Z4558 2021年4月 92Pages
QYResearch社発行の本調査資料では、医薬化学品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（溶剤、試薬/触媒、KSM/中間体、API用ビルディングブロック/アドバンスト中間体）、用途別市場規模（医療原料、美容製品、その他）、主要地域別...

世界の医薬化学品市場規模・現状・予測（2021年-2027年）

世界の脳血管障害市場規模・現状・予測（2021年-2027年） Cerebrovascular diseases are a group of condition characterized by a certain dysfunction of blood vessels supplying the brain and also affect the flow of blood in an individual’s brain. For proper functioning of the brain, it needs certain nutrients and oxygen from the arteries. However, if there is…
世界のパーキンソン病市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Parkinson's Disease Market The global Parkinson's Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report mak…
世界のパーキンソン病市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Parkinson's Disease Market The global Parkinson's Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report mak…
世界のパーキンソン病治療薬市場規模・現状・予測（2021年-2027年） Parkinson's disease is a type of progressive movement disorder, characterized by muscle rigidity, and tremors. Market Analysis and Insights: Global Parkinson’s Disease Therapeutics Market The global Parkinson’s Disease Therapeutics market size is projected to reach US$ 3533.7 million by 2026, from …
世界の脳疾患市場規模・現状・予測（2021年-2027年） Brain diseases a part of central nervous system diseases, is a condition where the brain structure or functions alter. The brain diseases include conditions or disabilities that affect the brain. Mostly brain disorders occur due to traumatic injury, genetic or other diseases, while a small number of…